
|Articles|February 8, 2020
Glaucoma 360 shines spotlight on innovation
Author(s)Sheryl Stevenson, Alex Delaney-Gesing
Advertisement
Glaucoma 360 co-founders and co-chairs Adrienne Graves, PhD, and Andrew Iwach, MD, sit down with Ophthalmology Times' Sheryl Stevenson to discuss a few of the highlights for this year’s meeting in San Francisco.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA extends Aldeyra's reproxalap PDUFA after requesting additional clinical study report
2
Spotlight on women's health: Understanding thyroid eye disease
3
Aviceda Therapeutics reports positive phase 2b SIGLEC results for AVD-104 in geographic atrophy
4
Argenx discontinues phase 3 UplighTED trials of efgartigimod SC in thyroid eye disease
5












































.png)


